CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

HR Notices From March 24

View Comments
(credit: istock) Technology Report
Read More

Diplomat Specialty Pharmacy Hires New CIO: Diplomat Specialty Pharmacy, the nation’s largest privately owned specialty pharmacy, announced today the hiring of David LeBlanc, an accomplished IT executive, as its CIO. LeBlanc will be responsible for the overall technology service delivery at Diplomat. He will report to CFO Sean Whelan. In his new role as CIO, LeBlanc will be responsible for developing a strategy to meet the future needs of Diplomat’s growing organization; providing leadership and oversight with the development and installation of Diplomat’s next generation patient care and dispensing systems; implementing new business and data warehousing systems; and building and executing Diplomat’s portal and mobility strategies. With more than 27 years of technology experience, LeBlanc has extensive experience in IT in a variety of industries, including air freight, distribution, anufacturing, engineering, marketing, health care, and most recently technology sales and service delivery. He has been involved in several high growth companies such as Zantop International Airlines, Klockner Namasco, Parks Production, Becker Group, Plastech Engineered Products and Compuware. LeBlanc has significant experience in mergers and acquisitions, supply chain management, business intelligence, enterprise resource planning, data management, software development lifecycle management and quality management. LeBlanc holds a technical degree in Management Information Systems from Michigan Technological Institute in Ann Arbor, and is also a certified project management professional registered with the Project Management Institute. Diplomat Specialty Pharmacy focuses on complete medication management programs for patients with serious and chronic conditions. Key programs include oncology, HIV-AIDS, hepatitis C, multiple sclerosis, rheumatoid arthritis, Crohn’s disease, hemophilia, growth hormone and psoriasis. More at www.diplomatpharmacy.com.

Jennifer Granholm Elected to Dow Board of Directors: Midland-based Dow Chemical Co. (NYSE: DOW) announced that Jennifer M. Granholm, former governor of the state of Michigan, has been elected to its Board of Directors, effective immediately. Granholm served as Governor of Michigan for two terms, from 2003–2011. Prior to being elected governor, she held a number of public service roles, including serving as Michigan’s first female attorney general. She is a graduate of Harvard Law School, was recently appointed a Distinguished Practitioner of Law and Public Policy at the University of California, Berkeley, and is a Senior Advisor to The Pew Charitable Trusts Clean Energy Program. “Jennifer Granholm’s experience and perspective will be instrumental as we continue to advocate for national and international policies that drive innovation, increase productivity, encourage investments in technology and create jobs,” said Andrew N. Liveris, Dow’s chairman and CEO. “During her tenure as governor, Granholm launched initiatives focused on diversifying and transforming the state’s economy by adding new, emerging sectors such as clean energy to Michigan’s economic portfolio, as well as creating jobs and training Michigan’s workers to promote the state’s long-term economic health. In addition, she has a demonstrated track record of cultivating many successful public- and private-sector collaborations that have laid the groundwork for profitable and sustainable growth for 21st century manufacturing.” For a complete list of Dow’s board members, committee assignments and other corporate governance information, visit the Corporate Governance section of www.dow.com.

View Comments
blog comments powered by Disqus